Top Markets
#1 Pleasing Gold Pleasing Gold +1,463.60%
#2 PulseChain PulseChain +59.45%
#3 Merlin's Seal BTC Merlin's Seal BTC +33.17%
#4 BOOK OF MEME BOOK OF MEME +31.56%
#5 Ontology Gas Ontology Gas +27.50%
#6 Unit Pump Unit Pump +24.39%
#7 Pump.fun Pump.fun +24.39%
#8 Nockchain Nockchain +22.61%
#9 ConstitutionDAO ConstitutionDAO +21.69%
#10 Neiro Neiro +19.99%
Coin of the day
Pleasing Gold Pleasing Gold
Settings
Language
ENGLISH
Currency
USD
Theme
Chordia Therapeutics Inc. Chordia Therapeutics Inc.

Chordia Therapeutics Inc.

190A
Rank in Stocks #26480
Chordia Therapeutics Inc., a biotech company, engages in research and... Chordia Therapeutics Inc., a biotech company, engages in research and development of anti-cancer drugs that targets RNA deregulation stress in Japan. It develops CLK CTX-712, a CLK inhibitor, which is Phase 1 clinical trial for the treatment of relapsed or refractory malignant cancers.; CTX-177, a small-molecule inhibitor of MALT1; CDK12 inhibitor CTX-439; and GCN2 inhibitor CRD-1968099. Chordia Therapeutics Inc. was incorporated in 2017 and is based in Fujisawa, Japan.
Share Price
$0.53499835
Market Cap
$40.24M
Change (1 day)
2.50%
Change (1 year)
-58.07%
Country
JP
Trade Chordia Therapeutics Inc. (190A)

Category

Healthcare
Dividend yield history for Chordia Therapeutics Inc. (190A)
Chordia Therapeutics Inc. (stock symbol: 190A) dividend yield (TTM) as of 2026: 0
Average dividend yield, last 5 years : 0.00%
Dividend yield history for Chordia Therapeutics Inc. (190A) from 2026 to 2026
Dividend Yield at the end of each year (TTM)
Year Dividend Yield Change
Not enough data for the provided dates.
Dividend yields (TTM) for similar companies or competitors
Company Dividend Yield Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH